Long-term follow-up after early intervention with intravenous diltiazem or intravenous nitroglycerin for unstable angina pectoris

European Heart Journal

Volumn 19, Issue 8, 1998, Pages 1208-1213

  Göbel, Erwin J A M ^b,c   Van Gilst, W H ^b   De Kam, P J ^b   Ter Napel, M G J ^b   Molhoek, G P ^a   Lie, K I ^b  

^a MEDISCH SPECTRUM TWENTE   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c LAURENTIUS HOSPITAL   (Netherlands)

Author keywords

Intravenous diltiazem; Prognosis; Unstable angina

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORONARY VASODILATING AGENT; DILTIAZEM; GLYCERYL TRINITRATE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; FOLLOW UP; HOSPITALIZATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; UNSTABLE ANGINA PECTORIS;

ANGINA, UNSTABLE; CALCIUM CHANNEL BLOCKERS; DILTIAZEM; DISEASE-FREE SURVIVAL; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; NITROGLYCERIN; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 0032147194     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.0874     Document Type: Article

References (24)

1. [1] Braunwald E. Unstable angina: a classification. Circulation 1989; 80: 410-14.
2. [2] Wilcox I, Freedman B, McCredie RJ, Carter GS, Kelly DT, Harris PJ. Risk of adverse outcome in patients admitted to the coronary care unit with suspected unstable angina pectoris. Am J Cardiol 1989; 64: 845-8.
3. [3] Smitherman TC. Southwestern Internal Medicine Conference: Unstable angina pectoris: The first half century: Natural history, pathophysiology, and treatment. Am J Med Sci 1986; 292: 395-406.
4. [4] Fulton M, Lutz W, Donald KW et al. Natural history of unstable angina. Lancet 1972; 1: 860-5.
5. [5] Mulcahy R, Daly L, Graham I et al. Unstable angina: Natural history and determinants of prognosis. Am J Cardiol 1981; 48: 525-8.
6. [6] Mulcahy R, Hai Al Awadhi A, Buitleor de M, Tobin G, Johnson H, Contoy R. Natural history and prognosis of unstable angina. Am Heart J 1985; 109: 735-8.
7. [7] Gazes PC, Mobley EM, Paris HM, Duncan RC, Humphries GB. Preinfarction (unstable) angina - a prospective study -ten year follow-up. Prognostic significance of electrocardiographic changes. Circulation 1973; 48: 331-7.
8. [8] Kraus KR, Hutter AM, DeSanctis RW. Acute coronary insufficiency. Course and follow-up. Arch Intern Med 1972; 129: 808-13.
9. [9] van Miltenburg-van Zijl AJM, Simoons ML, Veerhoek RJ, Bossuyt PMM. Incidence and follow-up of Braunwald sub-groups in unstable angina pectoris. J Am Coll Cardiol 1995; 25: 1286-92.
10. [10] Göbel EJAM, Hautvast RWM, van Gilst WH et al. Randomised, double-blind trial of intravenous diltiazem versus glyceryl trinitrate for unstable angina pectoris. Lancet 1995; 346: 1653-57.
11. [11] Furberg CD, Psaty BM, Meyer JV. Nifedipine. Dose-related increase in mortality in patients with coronary heart disease. Circulation 1995; 92: 1326-31.
12. [12] van Gilst WH, Lie KI. Calcium antagonism in perspective: new data on diltiazem in unstable angina. Eur Heart J 1996; 17: 485-6.
13. [13] Yusuf S, Wittes J, Friedman L. Overview of results of randomized trials in heart disease. II. Unstable angina, heart failure, primary prevention with aspirin, and risk factor modification. JAMA 1988; 260: 2259-63.
14. [14] Beller GA. Calcium antagonists in the treatment of Prinzmetal's angina and unstable angina pectoris. Circulation 1989; 80 (Suppl V): IV 78-87.
15. [15] Held PH, Yusuf S, Furberg D. Calcium channel blockers in acute myocardial infarction and unstable angina: an overview. Br Med J 1989; 299: 1187-92.
16. [16] Muller JE, Turi ZG, Pearle DL et al. Nifedipine and conventional therapy for unstable angina. A randomized, double-blind comparison. Circulation 1984; 69: 728-39.
17. [17] Holland Interuniversity Nifedipine/Metoprolol Trial (HINT) Research Group. Early treatment of unstable angina in the coronary care unit: a randomized, double-blind placebo controlled comparison of recurrent ischemia in patients treated with nifedipine or metoprolol or both. Br Heart J 1986; 56: 400-13.
18. [18] Farhi JI, Cohen M, Fuster V. The broad spectrum of unstable angina pectoris and its implications for future controlled trials. Am J Cardiol 1986; 58: 547-50.
19. [19] Gerstenblith G, Ouyang P, Achuff SC et al. Nifedipine in unstable angina. A double-blind randomized trial. N Engl J Med 1982; 306: 885-9.
20. [20] Cohen M, Adams PC, Hawkins L, Bach M, Fuster V. Usefulness of antithrombotic therapy in resting angina pectoris or non-Q-wave myocardial infarction (a pilot study from the Antithrombotic Therapy in Acute Coronary Syndromes Study Group). Am J Cardiol 1990; 66: 1287-92.
21. [21] Theroux P, Ouimet H, McCans J et al. Aspirin, heparin, or both to treat unstable angina. N Engl J Med 1988; 319: 1105-11.
22. [22] Cairns JA, Gent M, Singer J et al. Aspirin, sulfinpyrazone, or both in unstable angina. Results of a multicenter trial. N Engl J Med 1985; 313: 1396-75.
23. [23] The Rise group. Risk of myocardial infarction and death during treatment with low dose aspirin and intravenous heparin in men with unstable coronary artery disease. Lancet 1990; 336: 827-30.
24. [24] Betriu A, Heras M, Cohen M, Fuster V. Unstable angina: Outcome according to clinical presentation. J Am Coll Cardiol 1992; 19: 1659-63.